Compare
Two to four companies, one screen
The same numbers the feed and each dossier publish, lined up so you can weigh candidates against each other. Every figure is a public-filing estimate, identical for every subscriber, and the shaded cell in a row is simply the highest number in it — not a recommendation.
Add one more to line them up.
| Bayer OncologyFiled/Approved Remove | |
|---|---|
| Momentum0–100 | 71 |
| Runwayestimate, months | — |
| Stage | Filed/Approved |
| Last raiseForm D, self-reported | No Form D on file |
| Lead investigator | — |
| What changed | Filed/Approved trial registered: A Study to Learn More About How Safe Darolutamide is and How Well it Works Under Real World Conditions When Taken in Addition to Standard Androgen Deprivation Therapy (ADT) in Indian Participants With High-risk Non-metastatic Castration-resistant Prostate Cancer (nmCRPC)1w ago · Trial registered |
| Full dossier → |
Momentum and runway are estimates derived from public federal filings, published identically to every subscriber. This is informational only and is not investment advice. How the numbers work